Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Inventory (2016 - 2025)

Bio-Techne (TECH) has 16 years of Inventory data on record, last reported at $205.4 million in Q4 2025.

  • For Q4 2025, Inventory rose 9.06% year-over-year to $205.4 million; the TTM value through Dec 2025 reached $205.4 million, up 9.06%, while the annual FY2025 figure was $189.4 million, 5.41% up from the prior year.
  • Inventory reached $205.4 million in Q4 2025 per TECH's latest filing, up from $203.2 million in the prior quarter.
  • Across five years, Inventory topped out at $205.4 million in Q4 2025 and bottomed at $110.0 million in Q1 2021.
  • Average Inventory over 5 years is $163.8 million, with a median of $175.6 million recorded in 2023.
  • Peak YoY movement for Inventory: surged 32.1% in 2023, then dropped 0.56% in 2024.
  • A 5-year view of Inventory shows it stood at $121.9 million in 2021, then skyrocketed by 31.49% to $160.2 million in 2022, then increased by 12.86% to $180.8 million in 2023, then rose by 4.17% to $188.4 million in 2024, then rose by 9.06% to $205.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $205.4 million in Q4 2025, $203.2 million in Q3 2025, and $189.4 million in Q2 2025.